Guardant Health
GH
#1764
Rank
โ‚น1.123 T
Marketcap
โ‚น8,653
Share price
-0.14%
Change (1 day)
146.27%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น277.33

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น291.56. In 2024 the company made an earnings per share (EPS) of -โ‚น323.35 an increase over its 2023 EPS that were of -โ‚น388.75.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น277.33-14.23%
2024-โ‚น323.35-16.82%
2023-โ‚น388.75-33.13%
2022-โ‚น581.3160%
2021-โ‚น363.3255.04%
2020-โ‚น234.34207.14%
2019-โ‚น76.30-19.81%
2018-โ‚น95.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น251.65-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น194.38-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA